Equity in use of intermittent preventive treatment in pregnancy (IPTp).

<p>Percent women 15–49 who received 2 or more doses of sulfadoxine-pyrimethamine for IPTp during their last pregnancy, by rural versus urban residence and poorest versus wealthiest quintile, from national household surveys 2006–2008. Top group of countries are those achieving equity across rural-urban and wealth quintiles; bottom group are those not achieving equity across these categories. *Wealth statistically different (P-value<0.05); **Urban/rural statically different (P-value<0.05); ***Wealth and urban/rural statistically different (P-value<0.05); # Data are for sulfadoxine-pyrimethamine preventive use, but did not specify 2+ doses IPTp.